Previous 10 | Next 10 |
Applied Therapeutics ( APLT ) -22% on pricing $30M equity offering . Xenon Pharmaceuticals ( XENE ) -13% on pricing $250M equity offering . Clovis Oncology ( CLVS ) -10% Zai Lab ( ZLAB ) -9% on conversion of secondary listing in Ho...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the most impressive movers in today’s green market is Clovis Oncology (NASDAQ: CLVS ). Today, CLVS stock is up approximately 50% in this afternoon session on continued excitement around previously-...
3 Penny Stocks to Add to Your End of June Watchlist Finding penny stocks that are worth buying right now can be challenging. With so much volatility in the stock market, investors need to have a thorough understanding of exactly what is going on. This is the best and only way that trade...
Gainers: Convey Health Solutions Holdings (CNVY) +139%. Valneva (VALN) +86%. Green Giant (GGE) +78%. CEA Industries (CEAD) +76%. Clovis Oncology (CLVS) +71%. Tabula Rasa HealthCare (TRHC) +34%. Revlon (REV) +34%. Innate Pharma (IPHA) +33%. Sorrento Therapeutics (SRNE) +28%. MacroGenics (MGNX)...
Shares of Clovis Oncology (NASDAQ: CLVS) headed for the moon on Tuesday after the company reported positive interim phase 1/2 clinical trial results for one of its therapies on June 14, with its shares up by more than 65% as of 11 a.m. ET today before pulling back slightly. Of t...
Gainers: Convey Health Solutions CNVY +139%. Valneva VALN +87%. Clovis Oncology (CLVS) +34%. Innate Pharma (IPHA) +28%. Lexaria Bioscience (LEXX) +20%. Losers: ACADIA Pharmaceuticals ACAD -34%. Comera Life Sciences Holdings (CMRA) -17%. ...
Convey Health Solutions (CNVY) +138% on to be taken private by TPG. Valneva (VALN) +85% as Pfizer to buy 8.1% stake in Valneva. Innate Pharma (IPHA) +29%. BlackSky Technology (BKSY) +25% on being awarded up to $241M basic order agreement from JAIC. Symbotic (SYM) +17%. Clovis O...
Check These 3 Biotech Penny Stocks Out For Your Watchlist If you’re looking for biotech penny stocks to buy, there are hundreds of options to choose from. And while it may seem simple, it can be quite an arduous process to find biotech stocks that are worth investing in. Whil...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock / PopTika This week has been a relatively dismal one for overall markets. However, investors in specific companies like Clovis Oncology (NASDAQ: CLVS ) have seen impressive gains. CLVS st...
The June Federal Reserve meeting has concluded, and the stock market has responded. Investors and traders alike have begun positioning themselves based on the latest commentary from Jerome Powell’s FOMC press conference. The interesting part about this is that some stocks don’...
News, Short Squeeze, Breakout and More Instantly...
Receives Commitment for up to $75 Million in Debtor-in-Possession Financing Clovis Oncology, Inc. (NASDAQ:CLVS) (“Clovis” or the Company”), a biopharmaceutical company focused on acquiring, developing, and commercializing innovative anti-cancer agents in the U.S., E...